Camp4 Therapeutics News and Activities

Camp4 Therapeutics is a company listed under the stock ticker CAMP (US).

View the org chart displaying its 21 main executives

Most searched biographies at Camp4 Therapeutics

• Josh Mandel-Brehm, President, Chief Executive Officer and Director
• Andy Schwab, Director
• Michael MacLean, Director

Popular executive movements at Camp4 Therapeutics

• Michael Maclean has joined the company as Director  (posted on March 24 2026).

Create your alert
to follow the executive moves at Camp4 Therapeutics.

Camp4 Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Camp4 Therapeutics

• News Releases | CAMP4 Therapeutics
• News Releases | CAMP4 Therapeutics
• CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Thu, 05/21/2026 - 16:05
• CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder • Thu, 05/14/2026 - 07:00
• CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights • Thu, 05/07/2026 - 16:05
• CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation • Tue, 04/28/2026 - 08:00
• CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Fri, 04/17/2026 - 16:05
• CAMP4 Appoints Michael MacLean to its Board of Directors • Tue, 03/24/2026 - 07:00
• CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights • Thu, 03/05/2026 - 16:05
• CAMP4 to Participate in Upcoming Investor Conferences • Fri, 03/06/2026 - 16:05
• View more press releases Close

Social media about Camp4 Therapeutics

• Camp4 Therapeutics on Wikipedia, Google News & Yahoo Finance
• Camp4 Therapeutics on LinkedIn, X (Twitter) & YouTube